MYC and central nervous system cancer: Glycine production through serine hydroxymethyltransferase (SHMT)—a transcriptional target of c-Myc [69]—has been implicated as a driver of cancer cell proliferation in glioma [70] and many other types of tumors [71,72,73,74,75].